The Department of Pharmaceuticals (DoP) has come out with a draft National Pharmaceuticals Policy (NPP) 2023 emphasising on a holistic policy approach to address the challenges faced by Indian pharmaceutical industries and provide definitive policy interventions to enhance the collective ecosystem.
After years of constant denial, it appears that in the draft policy, the government is finally ready to accept that there is a problem with the drugs that are manufactured and sold in India.
The government has finalised the National Pharmaceuticals Pricing Policy 2012, which would replace the Drugs (Price Control) Order, 1994 that currently monitors and regulates prices of essential medicines in the country.
The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List of Essential Medicines ‐ 2011” as declared